Intuitive Machines vs. Rocket Lab: Which Space Stock Can Send Your Returns Into Orbit in 2026?

Intuitive Machines is favored over Rocket Lab for 2026 on valuation, trading at 4.6x sales versus Rocket Lab's 53.2x, despite both remaining loss-making and cash-flow negative. Intuitive Machines reported FY2025 revenue of $210.1 million (-7.9% YoY) and an $83.3 million net loss, but projects FY2026 revenue of $952 million, supported by a $1.1 billion backlog. Rocket Lab grew FY2025 revenue 38% to $601.8 million but posted a $198.2 million loss and faces financing and dilution risk from its proposed $8 billion acquisition of Iridium; the combined company is projected to generate $1.8 billion of 2026 revenue and approach breakeven.

Analysis

The apparent valuation discount in LUNR should not be treated as an apples-to-apples signal. Its prospective revenue step-up is likely dominated by milestone recognition and government-program timing rather than a recurring, diversified revenue base; any schedule slip, mission anomaly, or contract modification can therefore create an outsized quarterly reset. Negative equity also makes equity dilution the more likely funding mechanism if program cash conversion disappoints, despite adequate near-term liquidity.

RKLB merits a premium to LUNR because launch, space-systems manufacturing, and defense payloads create more cross-selling and customer diversification, but the current multiple leaves little room for execution slippage. The critical 1-3 month catalysts are Neutron schedule/capex updates, Electron cadence and margins, and evidence that space-systems backlog converts without working-capital drag. Over 6-18 months, successful medium-lift launch capability would pressure smaller launch peers and increase RKLB's strategic value versus pure satellite operators; a delay would instead expose the stock as a long-duration, cash-burning growth asset.

The reported IRDM transaction requires independent confirmation before it is incorporated into a fundamental thesis. If valid, the key issue is not headline revenue scale but financing terms: stock consideration, incremental debt, required regulatory approvals, and whether IRDM's durable service cash flow can fund RKLB's launch-development spend. Until a definitive filing establishes those terms, the market should assign a material probability to dilution and/or repricing rather than capitalize purported merger synergies.

Contrarian view: LUNR's lower sales multiple may be a risk signal, not mispricing. A concentrated contractor with binary mission exposure should trade at a discount to a diversified aerospace platform until it demonstrates repeatable gross-margin and operating-cash-flow conversion; the relevant catalyst is not backlog growth but backlog-to-cash conversion across multiple customers.

Key Decisions for Investors

• Avoid initiating a directional LUNR long solely on the forward sales estimate. Reassess after the next earnings release only if revenue concentration declines materially and operating cash flow improves; a guidance reduction or new equity issuance falsifies the turnaround case.
• For high-beta space exposure, prefer a 6-12 month long RKLB / short LUNR pair in equal dollar terms, entered following confirmation that RKLB's Neutron milestones remain on schedule. The thesis targets relative multiple support from diversification; exit if Neutron timing slips by more than one quarter or LUNR secures a second material customer.
• Treat IRDM as a transaction-watch rather than a recommendation until definitive merger documentation is available. If a binding deal is confirmed, evaluate the IRDM price versus stated consideration and hedge deal risk with a matched short RKLB only after financing, exchange ratio, and regulatory conditions are known.
• Set a risk alert on RKLB quarterly free-cash-flow burn and capital-expenditure guidance: a material increase without a corresponding funded backlog or launch-date progress would warrant reducing long exposure, as external financing risk becomes the dominant valuation driver.